Challenges in achieving the guideline-recommended amikacin level for Mycobacterium avium complex pulmonary disease
{{output}}
Background: The addition of aminoglycosides to a macrolide-based regimen is recommended for refractory Mycobacterium avium complex pulmonary disease (MAC-PD). For intravenous amikacin (AMK) administration three times a week, the ... ...
